Cat. No. 2578
Alternative Name: CGS 14824A
Chemical Name: (3S)-3-[[(1S)-1-(Ethoxycarbonyl)-3-
Biological ActivityNon-peptide angiotensin-converting enzyme (ACE) inhibitor. Reduces blood pressure and myocardial hypertrophy in spontaneous hypertensive rats.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Ishibashi et al (1991) Hemodynamic effects of benazepril, an angiotensin-converting enzyme inhibitor, as studied in conscious normotensive dogs. Cardiovas.Drugs Ther. 5 635.
Takemori et al (1991) Effect of benazepril hydrochloride on cardiac hypertrophy in spontaneous hypertensive rats. Arzneim.-Forsch. 41 612.
Yamamoto et al (1991) General pharmacology of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride. Effects on cardiovascular, visceral and renal functions and on hemodynamics. Arzneim.-Forsch. 41 913.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products. Selected citations for Benazepril hydrochloride include:
Bulavina et al (2013) NTPDase1 activity attenuates microglial phagocytosis. Purinergic Signal 9 199. PMID: 23208703.
Do you know of a great paper that uses Benazepril hydrochloride from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Benazepril hydrochloride, supplier, Angiotensin-converting, enzyme, ACE, inhibitors, inhibits, Proteinases, Proteases, CGS14824A, Tocris Bioscience, Angiotensin-Converting Enzyme Inhibitor products
Find multiple products by catalog number
New Products in this Area
Adam 17 (TACE) and MMP inhibitor; orally bioavailableRitonavir
HIV-1 and HIV-2 protease inhibitorAcetyl Pepstatin
High affinity aspartic protease inhibitor; inhibits HIV-1/2 proteinasesONO 6818
High affinity and selective human neutraphil elastase 1 (HNE1) inhibitor; orally activeTM 5275 sodium salt
Plasminogen activator inhibitor-1 (PAI-1) inhibitor; orally bioavailableSacubitril calcium
Membrane metallo-endopeptidase (neprilysin) inhibitor prodrug; orally bioavailable
November 12 - 16, 2016
San Diego, CA, USA